Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis

Sun, Renqiang, Zhang, Zhiyong, Bao, Ruoxuan, Guo, Xiaozhen, Gu, Yuan, Yang, Wenjing, Wei, Jinsong, Chen, Xinyu, Tong, Lingfeng, Meng, Jian, Zhong, Chen, Zhang, Cheng, Zhang, Jinye, Sun, Yiping, Ling, Chen, Tong, Xuemei, Yu, Fa-Xing, Yu, Hongxiu, Qu, Weifeng, Zhao, Bing, Guo, Wei, Qian, Maoxiang, Saiyin, Hexige, Liu, Ying, Liu, Rong-Hua, Xie, Cen, Liu, Weiren, Xiong, Yue, Guan, Kun-Liang, Shi, Yinghong, Wang, Pu, Ye, Dan·2022·Journal of Hepatology

Abstract

BACKGROUND & AIMS The liver is a metabolically active organ and is also 'tolerogenic' with sophisticated mechanisms of immune regulation to prevent pathogen attacks and tumorigenesis. How metabolism impacts the tumor microenvironment (TME) remains understudy. METHODS We investigated the role of metabolic regulator SIRT5 in hepatocellular caricinoma (HCC) development by conducting metabolomic analysis, gene expression profiling, flow cytometry and immunohistochemistry analyses in oncogene-induced HCC mouse models and human HCC samples. RESULTS We show that SIRT5 is downregulated in human primary HCC samples, and Sirt5 deficiency in mice synergizes with oncogenes to increase bile acid (BA) production, which is due to hypersuccinylation and increased BA biosynthesis in the peroxisome of hepatocytes. BA acts as a signaling mediator to stimulate its nuclear receptor and promote M2-like macrophage polarization, creating an immunosuppressive TME favorable for tumor initiating cells (TICs). In accord, high serum levels of taurocholic acid (T-CA) correlate with low SIRT5 expression and increased M2-like tumor-associated macrophages (TAMs) in HCC patient samples. Finally, administration of cholestyramine, a BA sequestrant and FDA-approved medication for hyperlipemia, reverses the effect of Sirt5 deficiency in promoting M2-like polarized TAMs and liver tumor growth. CONCLUSIONS This study uncovers a novel function of SIRT5 in orchestrating BA metabolism to prevent tumor immune evasion and suppress HCC development. Our results also suggest a potential strategy of using clinically proven BA sequestrants for the treatment of HCC patients, especially those with decreased SIRT5 and abnormally high BAs. LAY SUMMARY Hepatocellular caricinoma (HCC) development is closely linked to metabolic dysregulation and altered tumor microenvironment. Here, we show that loss of the metabolic regulator Sirt5 promotes hepatocarcinogenesis, which is associated with abnormally elevated bile acids and subsequently M2-like TAM polarization. We discover a mechanism of SIRT5 in suppressing HCC and a clinical strategy to promote a favorable TME for treatment of HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2022.02.030

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 184

Metadata

Authors
Sun, R., Zhang, Z., Bao, R., Guo, X., Gu, Y., Yang, W., Wei, J., Chen, X., Tong, L., Meng, J., Zhong, C., Zhang, C., Zhang, J., Sun, Y., Ling, C., Tong, X., Yu, F.-X., Yu, H., Qu, W., Zhao, B., Guo, W., Qian, M., Saiyin, H., Liu, Y., Liu, R.-H., Xie, C., Liu, W., Xiong, Y., Guan, K.-L., Shi, Y., Wang, P., & Ye, D.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2022-08
Volume
77
Issue
2
Pages
453-466
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4220812206
Cited by
184
References
11
FWCI
17.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis. https://app.cochat.ai/papers/10.1016/j.jhep.2022.02.030
The paper
Sun, R., Zhang, Z., Bao, R., Guo, X., Gu, Y., Yang, W., Wei, J., Chen, X., Tong, L., Meng, J., Zhong, C., Zhang, C., Zhang, J., Sun, Y., Ling, C., Tong, X., Yu, F.-X., Yu, H., Qu, W., . . . Ye, D. (2022). Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2022.02.030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.